Literature DB >> 14666113

Therapeutic vaccination for chronic diseases: a new class of drugs in sight.

Martin F Bachmann1, Mark R Dyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14666113     DOI： 10.1038/nrd1284

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  40 in total

Review 1.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

2.  Vaccine against PCSK9: the natural strategy from passive to active immunization for the prevention of atherosclerosis.

Authors:  Fernando Civeira; Estíbaliz Jarauta
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

Review 3.  Postexposure Effects of Vaccines on Infectious Diseases.

Authors:  Tara Gallagher; Marc Lipsitch
Journal:  Epidemiol Rev       Date:  2019-01-31       Impact factor: 6.222

4.  Modification of the RANKL-RANK-binding site for the immunotherapeutic treatment of osteoporosis.

Authors:  Y Ko; G Lee; B Kim; M Park; Y Jang; W Lim
Journal:  Osteoporos Int       Date:  2019-12-20       Impact factor: 4.507

5.  Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein.

Authors:  Dace Skrastina; Ivars Petrovskis; Rasa Petraityte; Irina Sominskaya; Velta Ose; Ilva Lieknina; Janis Bogans; Kestutis Sasnauskas; Paul Pumpens
Journal:  Clin Vaccine Immunol       Date:  2013-09-04

6.  Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes.

Authors:  Claudia Cavelti-Weder; Katharina Timper; Eleonora Seelig; Cornelia Keller; Martin Osranek; Ute Lässing; Gunther Spohn; Patrik Maurer; Philipp Müller; Gary T Jennings; Joerg Willers; Philippe Saudan; Marc Y Donath; Martin F Bachmann
Journal:  Mol Ther       Date:  2015-12-21       Impact factor: 11.454

7.  Versatile virus-like particle carrier for epitope based vaccines.

Authors:  Alain C Tissot; Regina Renhofa; Nicole Schmitz; Indulis Cielens; Edwin Meijerink; Velta Ose; Gary T Jennings; Philippe Saudan; Paul Pumpens; Martin F Bachmann
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

8.  The role of Ser-(Arg-Ser-Arg-Ser-GlucNAc)19-GlucNAc Fasciola gigantica glycoprotein in the diagnosis of prepatent fasciolosis in rabbits.

Authors:  Eman H Abdel-Rahman; Azza H Mohamed; Adel A H Abdel-Rahman; Eman E El Shanawany
Journal:  J Parasit Dis       Date:  2014-04-26

9.  Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model.

Authors:  Bryce Chackerian; Marisa R Durfee; John T Schiller
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

10.  Enhancing Dendritic Cell-based Immunotherapy with IL-2/Monoclonal Antibody Complexes for Control of Established Tumors.

Authors:  Marie T Kim; Martin J Richer; Brett P Gross; Lyse A Norian; Vladimir P Badovinac; John T Harty
Journal:  J Immunol       Date:  2015-09-25       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.